According to a new market report published by Lucintel, the future of the viral inactivation market looks promising with opportunities in applications, such as stem cell products, blood and blood related products, tissues & tissue related products, cellular & gene therapy products, and vaccines & therapeutics. The global viral inactivation market is expected to grow with a CAGR of 12% from 2020 to 2025. The major drivers for this market are rising investment in the life science sector, increasing launches & approvals for new drugs, and government support in funding for the development of the pharmaceutical and biopharmaceutical industries.
To download report brochure, please go to https://www.lucintel.com/viral-inactivation-market.aspx and click "download brochure" tab from the menu
Viral inactivation refers to a process of enhancing viral safety where virus is intentionally killed or made inactive. In this market, kits & reagents, services, and systems & accessories are the major products. Lucintel forecasts that kits & reagents will remain the largest segment over the forecast period due to growth in the pharmaceutical and biotechnology industries and rising R&D spending for new drug development.
Within this market, pharmaceutical and biotechnology companies will remain the largest end user segment over the forecast period because increasing investment to find alternative therapies has increased the development of new drugs and introduction of biologics and other cellular & gene therapy products.
North America will remain the largest region over the forecast period due to the presence of advanced healthcare infrastructure and significant expenditure on research and development activities by the government and companies in the region.
Clean Cells, Charles River Laboratories International, Danaher, Merck, Parker Hannifin, Rad Source Technologies, Sartorius, SGS, Texcell, and Viral Inactivated Plasma Systems are among the major suppliers in the global viral inactivation market.
Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global viral inactivation market by product, method, application, end user, and region. Lucintel has prepared a comprehensive research report titled “Growth Opportunities in the Global Viral Inactivation Market 2020-2025: Trends, Forecast, and Opportunity Analysis.” This Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global viral inactivation market by product, method, application, end user, and region as follows:
By Product [Value ($ Million) shipment analysis for 2014 – 2025]:
Kits & Reagents
Services
Systems & Accessories
By Method [Value ($ Million) shipment analysis for 2014 – 2025]:
Solvent Detergent
Pasteurization
Other Methods
By Application [Value ($ Million) shipment analysis for 2014 – 2025]:
Stem Cell Products
Blood and Blood Products
Tissues & Tissue Products
Cellular & Gene Therapy Products
Vaccines & Therapeutics
By End User [Value ($ Million) shipment analysis for 2014 – 2025]:
Pharmaceutical and Biotechnology Companies
Contract Research Organizations (CROs)
Academic Research Institutes
Other End Users
By Region [Value ($ Million) shipment analysis for 2014 – 2025]:
United States
Canada
Mexico
United Kingdom
Spain
Germany
France
This 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or visit us at helpdesk@lucintel.com.
About Lucintel
Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. It offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision makers in a variety of industries. For further information, visit www.lucintel.com.